MATTISON PEREZ: Open Payments
NPI 1003285560 · BELLEVILLE, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$442 in 22 payments from 11 companies in 2025. Trend: 2023 $2,071 · 2024 $2,056 · 2025 $442
Food & beverage: $442
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 4 | $93 |
| Novo Nordisk Inc | 4 | $82 |
| ABBVIE INC. | 3 | $54 |
| Janssen Pharmaceuticals, Inc | 2 | $42 |
| Amgen Inc. | 2 | $35 |
| AstraZeneca Pharmaceuticals LP | 2 | $31 |
| Vanda Pharmaceuticals Inc. | 1 | $29 |
| Paratek Pharmaceuticals, Inc. | 1 | $24 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $24 |
| Exact Sciences Corporation | 1 | $14 |
Products named: MOUNJARO, Ozempic, QULIPTA, SPRAVATO, OTEZLA, FANAPT, NUZYRA, CAPLYTA.
Industry payments across IL — which companies pay providers there.
